The company recently published a clinical study showing the test could distinguish between bacterial and viral infections with an area under the curve of .94.
The study found that using Veristrat to guide patient therapy decreased the total lifetime direct medical cost per patient by $135.
The company has launched an early-access program for researchers interested in using the system for fractionation of proteomic samples.
OVA2 replaces two of the five OVA1 protein markers with new biomarkers and offers improved specificity and positive predictive value, the company said.
Product revenues, comprised of OVA1 sales, were also flat at $1.5 million, as were licensing revenues at $113,000.
In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.
GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.
Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.
A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.